Your browser doesn't support javascript.
loading
Dual PI3K/mTOR inhibition is required to effectively impair microenvironment survival signals in mantle cell lymphoma.
Rosich, Laia; Montraveta, Arnau; Xargay-Torrent, Sílvia; López-Guerra, Mónica; Roldán, Jocabed; Aymerich, Marta; Salaverria, Itziar; Beà, Sílvia; Campo, Elías; Pérez-Galán, Patricia; Roué, Gaël; Colomer, Dolors.
Afiliação
  • Rosich L; Experimental Therapeutics in Lymphoid Malignancies Group, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.
  • Montraveta A; Experimental Therapeutics in Lymphoid Malignancies Group, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.
  • Xargay-Torrent S; Experimental Therapeutics in Lymphoid Malignancies Group, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.
  • López-Guerra M; Experimental Therapeutics in Lymphoid Malignancies Group, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.
  • Roldán J; Experimental Therapeutics in Lymphoid Malignancies Group, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.
  • Aymerich M; Hematopathology Unit, Department of Pathology, Hospital Clínic, Barcelona, Spain. IDIBAPS, University of Barcelona, Barcelona, Spain.
  • Salaverria I; IDIBAPS, University of Barcelona, Barcelona, Spain.
  • Beà S; IDIBAPS, University of Barcelona, Barcelona, Spain.
  • Campo E; Hematopathology Unit, Department of Pathology, Hospital Clínic, Barcelona, Spain. IDIBAPS, University of Barcelona, Barcelona, Spain.
  • Pérez-Galán P; Experimental Therapeutics in Lymphoid Malignancies Group, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.
  • Roué G; Experimental Therapeutics in Lymphoid Malignancies Group, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.
  • Colomer D; Experimental Therapeutics in Lymphoid Malignancies Group, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain. Hematopathology Unit, Department of Pathology, Hospital Clínic, Barcelona, Spain.
Oncotarget ; 5(16): 6788-800, 2014 Aug 30.
Article em En | MEDLINE | ID: mdl-25216518
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linfoma de Célula do Manto / Inibidores de Proteínas Quinases / Serina-Treonina Quinases TOR / Inibidores de Fosfoinositídeo-3 Quinase Limite: Humans Idioma: En Revista: Oncotarget Ano de publicação: 2014 Tipo de documento: Article País de afiliação: Espanha País de publicação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linfoma de Célula do Manto / Inibidores de Proteínas Quinases / Serina-Treonina Quinases TOR / Inibidores de Fosfoinositídeo-3 Quinase Limite: Humans Idioma: En Revista: Oncotarget Ano de publicação: 2014 Tipo de documento: Article País de afiliação: Espanha País de publicação: Estados Unidos